Hims & Hers Health shares stabilize after boosted $350 mln convertible deal

Hims & Hers Health

19/05/2026 11:43

* Telehealth firm Hims & Hers Health HIMS.N shares down 0.4% premarket to $22.20 after above-target raise

** San Francisco, California-based firm late Mon announced pricing private offering of $350 mln 0% convertible bonds due 2032

** Initial conversion price of $29.53 is 32.5% premium to stock's last sale of $22.29

** HIMS stock closed down 11% on Mon after co announced $300 mln offering to support international expansion, including proposed acquisition of Australia's Eucalyptus, and for scaling AI capabilities

** On May 12, stock shed 14% after co posted qtrly rev miss and surprise loss, as shift toward branded GLP-1 weight-loss drugs squeezed margins and clipped U.S. sales

** Stock down 31% YTD at last close

** 12 of 17 analysts rate the stock "hold", 5 rate "buy"; median PT $25, according to LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))